Results 71 to 80 of about 334,393 (231)
Journal of Thoracic Disease, 2020 Thymic tumours are a heterogeneous group of malignancies with a range of clinical presentations. The most common types are thymoma and thymic carcinoma, but overall it remains a rare cancer, and one without a clear aetiology. In this review of the epidemiology of the disease, the relationship between sex, age, and ethnicity is reviewed, along with ...
openaire +2 more sources
Cancer Science, EarlyView.The antitumor immune response is attenuated in T cell‐specific Ezh2 knockout mice. ABSTRACT Appropriate regulation of the differentiation balance between effector CD8+ T cells and memory CD8+ T cells is crucial for an appropriate immune response. We previously reported that the tumor suppressor menin suppresses the differentiation of CD8+ T cells into ...
Kenji Takagi +5 more
wiley +1 more source
, 2007 Thymoma associated with hypogammaglobulinemia and profound susceptibility to recurrent and serious infections was first reported by Good in 1954, after whom it was named as Good's syndrome.
Kaynak, Kamil +8 more
core +1 more source
Computed Tomography differential features of Anterior Mediastinal Thymoma and Lymphoma
International Journal of Endorsing Health Science Research, 2017 Background: To identify the CT features of anterior mediastinal thymoma and lymphoma and evaluate CT findings that may help in suggesting specific diagnosis among these tumors.
Sagar Thapa +5 more
doaj +1 more source
Treatment of Recurrent Thymoma
Chinese Journal of Lung Cancer, 2020 Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma.
Xianping LIU, Xiao LI, Jianfeng LI
doaj +1 more source
Pleiotropic Roles of FBXO11 in Tumorigenesis: Implications for Targeted Therapy
Cancer Science, EarlyView.This complex comprises of scaffold CUL1, SKP1, RBX1 and FBXO11 receptor. The substrate is phosphorylated by specific kinase enzyme and recognized by the substrate recognition domain. FBXO11 targets numerous substrates for ubiquitination and degradation, FBXO11 substrates mainly include Snail, ZEB1, p53, BCL6, CDT2, CIITA, Cdc25a, hnRNPA2B1, SAMD1 and ...
Yuqi Zhang +6 more
wiley +1 more source
Thymoma with Autoimmune Hemolytic Anemia
, 2014 A 38-year-old Japanese male was referred to our hospital with abnormal chest X-ray results and severe Coombs-positive hemolytic anemia. He was diagnosed with a stage IV, WHO type A thymoma and was treated with oral prednisolone (1 mg/kg/day) and ...
Ryuji Hayashi +4 more
core +1 more source
Bioinformatics and Biology InsightsBackground: Thymoma is a key risk factor for myasthenia gravis (MG). The purpose of our study was to investigate the potential key genes responsible for MG patients with thymoma.
Hui Liu +4 more
doaj +1 more source
Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India [PDF]
Journal of Clinical and Diagnostic Research, 2014 Introduction:18 Fluorine-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F- FDG-PET/CT) is of importance in assessing high-risk thymoma and thymic carcinomas.
Julie Hephzibah +2 more
doaj +1 more source
Thymoma and autoimmunity [PDF]
Cellular & Molecular Immunology, 2011 The thymus is a central lymphatic organ that is responsible for many immunological functions, including the production of mature, functional T cells and the induction of self-tolerance. Benign or malignant tumors may originate from the thymus gland, with thymoma being the most common and accounting for 50% of anterior mediastinal tumors.
Shahar, Shelly +3 more
openaire +2 more sources